Int J Behav Med. 2021 May 19; doi: 10.1007/s12529-021-10002-4. Epub 2021 May 19.

Effects of Mindfulness-Based Relapse Prevention on the Chronic use of Hypnotics in Treatment-Seeking Women with Insomnia: a Randomized Controlled Trial.

International journal of behavioral medicine

Viviam Vargas Barros, Emérita Sátiro Opaleye, Marcelo Demarzo, Daniela Fernández Curado, Sarah Bowen, Helena Hachul, Ana Regina Noto

PMID: 34013489 DOI: 10.1007/s12529-021-10002-4

Abstract

BACKGROUND: Hypnotics are one of the most frequently prescribed drugs worldwide, especially for women, and their chronic use may lead to tolerance, dosage escalation, dependence, withdrawal syndrome, and cognitive impairments, representing a significant public health problem. Consistent evidence from previous studies shows benefits of mindfulness-based interventions (MBIs) for substance use disorders (SUD) and insomnia. However, to date, there is a lack of research about effects of MBIs on reduction/cessation of chronic hypnotic use among women with insomnia.

METHOD: The present randomized trial evaluated the efficacy of the 8-week group-delivered mindfulness-based relapse prevention (MBRP) program in an intervention group (IG, n = 34) compared with weekly phone monitoring only in the control group (CG, n = 36) in reducing hypnotic use and insomnia severity over a 6-month follow-up period.

RESULTS: There were significant differences between groups at baseline regarding hypnotic use but not insomnia. Group effects on hypnotic use were found immediately after the intervention (bT1 = 2.01, p < 0.001) and at the 2-month follow-up (bT2 = 2.21, p < 0.001), favoring the IG. The IG also had a greater reduction from baseline levels than the control group in insomnia severity at the 4-month (bT3 = 0.21, p = 0.045) and 6-month (bT4 = 0.32, p = 0.002) follow-ups.

CONCLUSIONS: The findings provide preliminary evidence of benefits of MBRP for reducing insomnia severity and potentially chronic hypnotic use. However, IG effects on chronic hypnotic use may have resulted from IG and control group differences in chronic hypnotic use at baseline.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02127411.

Keywords: Benzodiazepines; Hypnotics and sedatives; Insomnia; Mindfulness; Mindfulness-based relapse prevention (MBRP); Z-drugs

References

1. Castro LS, Poyares D, Leger D, Bittencourt L, Tufik S. Objective prevalence of insomnia in the São Paulo, Brazil epidemiologic sleep study. Ann Neurol. 2013;74:537–46. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ana.23945 - PubMed
2. Fiorelli K, Assini F. A prescrição de benzodiazepínicos no Brasil: uma análise da literatura. ABCS Heal Sci. 2017;42. - PubMed
3. de Campos HH, Bittencourt LRA, Haidar MA, Tufik S, Baracat EC. Prevalência de distúrbios do sono na pós-menopausa. Rev Bras Ginecol e Obs. 2005;27:731–6. - PubMed
4. Cuadros JL, Fernández-Alonso AM, Cuadros-Celorrio ÁM, Fernández-Luzón N, Guadix-Peinado MJ, del Cid-Martín N, et al. Perceived stress, insomnia and related factors in women around the menopause. Maturitas. 2012;72:367–72. Available from: http://www.sciencedirect.com/science/article/pii/S037851221200196X - PubMed
5. Jansson-Fröjmark M, Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res England. 2008;64:443–9. - PubMed
6. Guina J, Merrill B. Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. J Clin Med. 2018;7. - PubMed
7. Willems IAT, Gorgels WJMJ, Oude Voshaar RC, Mulder J, Lucassen PLBJ. Tolerance to benzodiazepines among long-term users in primary care. Fam Pract. 2013;30:404—410. Available from: https://doi.org/10.1093/fampra/cmt010 - PubMed
8. Ashton CH. Benzodiazepines: how they work and how to withdraw. 2002. Available from: https://benzo.org.uk/manual/index.htm.2002 - PubMed
9. Brandt J, Leong C. Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. Springer International Publishing; 2017;17:493–507. Available from: https://pubmed.ncbi.nlm.nih.gov/28865038 - PubMed
10. Dell’osso B, Lader M. Do benzodiazepines still deserve a major role in the treatment of psychiatric disorders? A critical reappraisal. Eur Psychiatry. England; 2013;28:7–20. - PubMed
11. Schonmann Y, Goren O, Bareket R, Comaneshter D, Cohen AD, Vinker S. Chronic hypnotic use at 10 years—does the brand matter? Eur J Clin Pharmacol. 2018;74:1623–31. Available from: https://doi.org/10.1007/s00228-018-2531-4 - PubMed
12. Taylor DJ, Schmidt-Nowara W, Jessop CA, Ahearn J. Sleep restriction therapy and hypnotic withdrawal versus sleep hygiene education in hypnotic using patients with insomnia. J Clin Sleep Med. 2010;6:169—175. Available from: https://europepmc.org/articles/PMC2854705 - PubMed
13. Soeffing JP, Lichstein KL, Nau SD, McCrae CS, Wilson NM, Aguillard RN, et al. Psychological treatment of insomnia in hypnotic-dependant older adults. Sleep Med. 2007/07/17. 2008;9:165–71. Available from: https://pubmed.ncbi.nlm.nih.gov/17644419 - PubMed
14. Belleville G, Guay C, Guay B, Morin C. Hypnotic taper with or without self-help treatment of insomnia: a randomized clinical trial. J Consult Clin Psychol. 2007;75:325–35. - PubMed
15. Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technol Assess. England; 2004;8:iii–iv, 1–68. - PubMed
16. Firmino KF, de Abreu MHNG, Perini É, de Magalhães SMS. Utilização de benzodiazepínicos no Serviço Municipal de Saúde de Coronel Fabriciano. Minas Gerais Cien Saude Colet. 2012;17:157–66. - PubMed
17. Cheung J, Bartlett D, Armour C, Laba T-L, Saini B. To drug or not to drug: a qualitative study of patients’ decision-making processes for managing insomnia. Behav Sleep Med. 2016;16:1–26. - PubMed
18. de Souza ARL, Opaleye ES, Noto AR. Contexts and patterns of undue use benzodiazepine among women. Cien Saude Colet Brazil. 2013;18:1131–40. - PubMed
19. Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN. General practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract. 2013;14:191. - PubMed
20. Hachul H, Noto AR, Demarzo M, Kozasa EH, Tufik S, Andersen ML. Rapid Response to: Benzodiazepine use and risk of dementia: prospective population based study. BMJ Br Med J. 2013;345. - PubMed
21. Gong H, Ni C-X, Liu Y-Z, Zhang Y, Su W-J, Lian Y-J, et al. Mindfulness meditation for insomnia: a meta-analysis of randomized controlled trials. J Psychosom Res England. 2016;89:1–6. - PubMed
22. Barros VV, Opaleye ES, Demarzo M, Bowen S, Curado DF, Hachul H, et al. Dispositional mindfulness, anticipation and abstinence symptoms related to hypnotic dependence among insomniac women who seek treatment: a cross-sectional study. PLoS One. 2018;13. - PubMed
23. Li W, Howard MO, Garland EL, McGovern P, Lazar M. Mindfulness treatment for substance misuse: a systematic review and meta-analysis. J Subst Abuse Treat United States. 2017;75:62–96. - PubMed
24. Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, et al. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin Psychol Rev. Elsevier; 2018;59:52–60. Available from:  https://doi.org/10.1016/j.cpr.2017.10.011 - PubMed
25. Ong JC, Ulmer CS, Manber R. Improving sleep with mindfulness and acceptance: a metacognitive model of insomnia. Behav Res Ther. 2012;50:651–60. - PubMed
26. Miller WR, Rollnick S. Motivational Interviewing: Helping people change. 3rd ed. New York: The Gilford Press; 2013. - PubMed
27. Hester RK, Miller WR. Handbook of alcoholism treatment approaches: effective alternatives. Boston: Pearson; 2003. - PubMed
28. Bowen S, Chawla N, Marlatt GA. Mindfulness-based relapse prevention for addictive behaviors: a clinician’s guide. New York: Guilford Press; 2011. - PubMed
29. Crane RS, Kuyken W. The Mindfulness-Based Interventions: Teaching Assessment Criteria (MBI:TAC): reflections on implementation and development. Curr Opin Psychol. 2019;28:6–10. Available from: http://www.sciencedirect.com/science/article/pii/S2352250X18301507 - PubMed
30. Brandt J, Alkabanni W, Alessi-Severini S, Leong C. Translating benzodiazepine utilization data into meaningful population exposure: integration of two metrics for improved reporting. Clin Drug Investig New Zealand. 2018;38:565–72. - PubMed
31. Velásquez M, Maurer G, Crouch C, DiClemente C. Group treatment for substance abuse: a stages-of-change therapy manual. New York: The Guilford Press; 2001. - PubMed
32. Castro LS. Adaptação e validação do Índice de Gravidade de Insônia (IGI): caracterização populacional, valores normativos e aspectos associados. Universidade Federal de São Paulo; 2011. - PubMed
33. Opsal A, Kristensen Ø, Clausen T. Readiness to change among involuntarily and voluntarily admitted patients with substance use disorders. Subst Abuse Treat Prev Policy. 2019;14:47. - PubMed
34. Brooks ME, Kristensen K, van Benthem KJ, Magnusson A, Berg CW, Nielsen A, et al. glmmTMB balances speed and flexibility among packages for zero-inflated generalized linear mixed modeling. R J. 2017;9:378–400. - PubMed
35. Lüdecke D. SjPlot: data visualization for statistics in social science. 2020. Available from: https://cran.r-project.org/package=sjPlot - PubMed
36. Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer-Verlag; 2016. Available from: https://ggplot2.tidyverse.org . - PubMed
37. Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European Union: a systematic review of the literature. Eur Addict Res Switzerland. 2012;18:228–45. - PubMed
38. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol England. 2005;34:215–20. - PubMed
39. Mugunthan K, McGuire T, Glasziou P. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Database Abstr Rev Eff Qual Rev. York: Centre for Reviews and Dissemination (UK); 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK91919/ - PubMed
40. Lunde L-H, Skjotskift S. Combining mindfulness meditation with cognitive behavior therapy and medication taper for hypnotic-dependent insomnia in older adults: a case study. Clin Case Stud. 2015;14:307–20. - PubMed
41. Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N, Hsu SH, et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiat. 2014;71:547–56. - PubMed
42. Wu L, He Y, Jiang B, Zhang D, Tian H, Zuo F, et al. Very brief physician advice and supplemental proactive telephone calls to promote smoking reduction and cessation in Chinese male smokers with no intention to quit: a randomized trial. Addiction. John Wiley & Sons, Ltd; 2017;112:2032–40. Available from: https://doi.org/10.1111/add.13908 - PubMed
43. Hachul H, Brandão LC, D’Almeida V, Bittencourt LRA, Baracat EC, Tufik S. Isoflavones decrease insomnia in postmenopause. Menopause United States. 2011;18:178–84. - PubMed
44. Garcia MC, Kozasa EH, Tufik S, Mello LEAM, Hachul H. The effects of mindfulness and relaxation training for insomnia (MRTI) on postmenopausal women: a pilot study. Menopause United States. 2018;25:992–1003. - PubMed
45. Malinowski P. Neural mechanisms of attentional control in mindfulness meditation. Front Neurosci. 2013;7:8. - PubMed
46. Hubbling A, Reilly-Spong M, Kreitzer MJ, Gross CR. How mindfulness changed my sleep: focus groups with chronic insomnia patients. BMC Complement Altern Med. 2014;14:50. - PubMed
47. Garland SN, Zhou ES, Gonzalez BD, Rodriguez N. The quest for mindful sleep: a critical synthesis of the impact of mindfulness-based interventions for insomnia. Curr sleep Med reports. 2016;2:142–51. - PubMed
48. Anthierens S, Habraken H, Petrovic M, Deveugele M, De Maeseneer J, Christiaens T. First benzodiazepine prescriptions: qualitative study of patients’ perspectives. Can Fam Physician. 2007;53:1200–1. - PubMed
49. Altman DG. Comparability of randomised groups. J R Stat Soc Ser D The Stat. [Royal Statistical Society, Wiley]; 1985;34:125–36. Available from: http://www.jstor.org/stable/2987510 - PubMed
50. Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M. Reenvisioning clinical science: unifying the discipline to improve the public health. Clin Psychol Sci. SAGE Publications Inc; 2013;2:22–34. Available from: https://doi.org/10.1177/2167702613497932 - PubMed

Publication Types

• Journal Article

Grant support

• 2013/20367-6/FAPESP
• 407116/2013-3407116/2013-3/Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)